The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau‐methylimidazole acetic acid in urine of patients with mastocytosis.

British Journal of Clinical Pharmacology

Volumn 27, Issue 1, 1989, Pages 88-91

  Mallet, AI ^a   Norris, P ^a   Rendell, NB ^a   Wong, E ^a   Greaves, MW ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; HISTAMINE; KETOTIFEN;

ADULT; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; MALE; MASTOCYTOSIS; METHYLIMIDAZOLEACETIC ACID; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINALYSIS;

ADULT; CASE REPORT; CROMOLYN SODIUM; FEMALE; HISTAMINE; HUMAN; IMIDAZOLES; KETOTIFEN; MALE; MASTOCYTOSIS; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0024579966     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1989.tb05339.x     Document Type: Article

References (11)

1. Ketotifen: current views on its mechanism of action and their therapeutic implications.
2. Comparison of the therapeutic efficacy of cromolyn disodium with that of combined chloropheniramine and cimetidine in systemic mastocytosis.
3. Association of platelet activating factor with primary, acquired cold urticaria.
4. 2 and histamine release in cold urticaria.
5. Prevention of mast cell degranulation by ketotifen in patients with physical urticarias.
6. Factitious wealing at the site of a previous cutaneous response.
7. Analysis of NT‐methylimidazole acetic acid by electron impact gas chromatography‐mass spectrometry.
8. 2 in patients with systemic mastocytosis.
9. Comparative evaluation of the radio‐enzymatic method for the determination of urinary histamine with a mass spectrometric assay.
10. Tryptase levels as an indicator of mast‐cell activation in systemic anaphylaxis and mastocytosis.
11. Oral disodium cromoglycate in the treatment of systemic mastocytosis.